2025-04-17 - Analysis Report
## Equinix Inc. (EQIX) Stock Report

**0. Key Figures Overview:**

Equinix Inc. (EQIX) is a global digital infrastructure company offering data centers and interconnection services.  The company shows a cumulative return significantly outperforming the S&P 500 (VOO) over the analyzed period. Recent price movements indicate a slight downward trend, while financial indicators present a mixed picture.

**1. Performance Comparison & Alpha/Beta Analysis:**

EQIX's cumulative return of 78.41% significantly outperforms the S&P 500's 76.08% return, resulting in a positive divergence of 2.3 percentage points.  The relative divergence of 34.2% indicates that EQIX's performance is in the upper range of its historical performance relative to the S&P 500.

The Alpha/Beta analysis reveals fluctuating alpha values (ranging from -0.33 to 0.9), suggesting varying degrees of outperformance compared to the market benchmark. The beta consistently remains high (between 30.8 and 77.7), indicating significant market sensitivity.  Note that the CAGR shows significant variability, and there are periods where the company underperformed (e.g., 2016-2018, 2021-2023).


**2. Recent Price Movement:**

* **Closing Price:** $778.68
* **5-day moving average:** $779.52
* **20-day moving average:** $802.68
* **60-day moving average:** $868.58

The closing price is below all three moving averages, suggesting a downward trend in the short to medium term.  The recent price change (-1.12) represents a minor daily decrease and needs further observation to determine if it's part of a larger trend or a temporary fluctuation.

**3. Technical Indicators & Expected Return:**

* **Market Risk Indicator (MRI):** 0.41 (Medium Risk)
* **RSI:** 40.75 (Approaching oversold territory, but not yet decisively so)
* **PPO:** 0.18 (Positive, suggesting potential upward momentum)
* **20-day Relative Divergence Change:** +1.1 (Short-term upward trend)
* **Expected Return:** 13.5% (over S&P 500 over a long-term (2+ years) holding period)

The indicators present a mixed signal. While the RSI suggests potential for a bounce, the price is below its moving averages.  The positive PPO and relative divergence suggest some short-term bullishness.  The expected return is notable and would need to account for both market conditions and company-specific factors. The recent negative price change is relatively small and doesn't signal a dramatic downturn, but warrants monitoring.

**4. Recent Earnings Analysis:**

| Date       | EPS   | Revenue       |
|------------|-------|---------------|
| 2024-10-30 | 3.11  | $2.20 B      |
| 2024-08-07 | 3.17  | $2.16 B      |
| 2024-05-08 | 2.44  | $2.13 B      |
| 2023-10-27 | 2.94  | $2.06 B      |
| 2024-10-30 | 2.94  | $2.06 B      | *(Duplicate entry, possibly an error)*


EPS shows some fluctuation but generally remains strong, indicating consistent profitability. Revenue shows relatively stable growth.  The duplicate entry needs clarification.

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $2.26B | 47.10%       |
| 2024-09-30 | $2.20B | 50.11%       |
| 2024-06-30 | $2.16B | 49.88%       |
| 2024-03-31 | $2.13B | 48.71%       |
| 2023-12-31 | $2.11B | 48.27%       |

Revenue is steadily increasing, and profit margins remain strong and relatively consistent, indicating good financial health.


**Capital and Profitability:**

| Quarter | Equity    | ROE     |
|---------|-----------|---------|
| 2024-12-31 | $13.53B  | -0.10%  |
| 2024-09-30 | $13.59B  | 2.19%   |
| 2024-06-30 | $12.28B  | 2.45%   |
| 2024-03-31 | $12.30B  | 1.88%   |
| 2023-12-31 | $12.49B  | 1.82%   |

Equity shows some fluctuation. ROE is generally positive but exhibits variability. The negative ROE in Q4 2024 requires further investigation to understand the underlying causes.


**6. Overall Analysis:**

EQIX demonstrates strong long-term performance relative to the S&P 500, although recent price action suggests a short-term downward trend.  Financial performance (revenue and profit margins) remains healthy. However, some inconsistencies exist in ROE and the need to clarify the duplicate earnings data point. The medium risk indicator from MRI and the mixed technical signals indicate a need for cautious optimism.  Further analysis is recommended, especially investigating the reasons for the negative ROE in Q4 2024 and the duplicate earnings data point.  The high beta suggests significant market sensitivity, so broader market conditions will significantly influence EQIX's performance. The long-term expected return remains attractive, but potential investors should carefully weigh the risks and rewards given the market volatility and recent price movement.
